Rajveer Sachdev, MD
Family Medicine · Pomona, NYNPI 1275624660
Payments from drug & device makers
Across 1,237 payments — averaging $170.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$193K
- Corcept Therapeutics$3K
- Novo Nordisk$3K
- AstraZeneca$2K
- AbbVie$1K
- Bayer$1K
- plus $6K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 458 | $193,179 |
| Corcept Therapeutics | 25 | $3,214 |
| Novo Nordisk | 186 | $2,903 |
| AstraZeneca | 114 | $2,489 |
| AbbVie(2 entities) | 89 | $1,407 |
| Bayer | 41 | $1,160 |
| Boehringer Ingelheim | 53 | $1,033 |
| Pfizer | 48 | $968 |
| GSK | 48 | $857 |
| Exact Sciences | 16 | $344 |
| Novartis | 15 | $341 |
| Kowa Pharmaceuticals America, Inc. | 17 | $313 |
| Currax Pharmaceuticals LLC | 20 | $305 |
| Sanofi-aventis U.S. LLC | 15 | $300 |
| Merck | 17 | $255 |
| Johnson & Johnson | 14 | $249 |
| Axsome Therapeutics, Inc. | 5 | $226 |
| Arbor Pharmaceuticals, Inc. | 13 | $224 |
| Amgen(2 entities) | 8 | $161 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $96 |
| Teva Pharmaceuticals USA, Inc. | 5 | $79 |
| Azurity Pharmaceuticals, Inc. | 4 | $76 |
| Lundbeck LLC | 3 | $59 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Gilead | 3 | $48 |
| Genentech USA, Inc. | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Biogen | 1 | $26 |
| Sanofi Pasteur Inc. | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $19 |
| Abbott | 1 | $19 |
| Astellas Pharma US Inc | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
How this compares
$210,559 in reported general payments places this provider in the 95th percentile of 4,321 family medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Pomona
- Matthew DavisRochester$76.6M
- Frank EderBinghamton$46.2M
- Suchet PatelEndwell$23.3M
- James WildGowanda$2.2M
- Michael FedericoEndwell$1.4M
- Donald BrautigamWestfield$1.3M
- Kimberly DesantisEndwell$1.1M
- Michael TugetmanHartsdale$1M
- Richard RuhOrchard Park$769K
- Eric LorraineEndwell$740K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.